
Sign up to save your podcasts
Or


Today on the Medscape Medical Minute: SPRINT trial mortality benefits stopped when the trial ended; islet cell transplantation is durable up to 8 years in type 1 diabetes; and is the CDC's 5-day isolation recommendation the best approach?
By MedscapeToday on the Medscape Medical Minute: SPRINT trial mortality benefits stopped when the trial ended; islet cell transplantation is durable up to 8 years in type 1 diabetes; and is the CDC's 5-day isolation recommendation the best approach?